Author

Meryem Seda Ercanoglu

University of CologneORCID 0000-0001-8026-8565Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2

Frequent Co-Authors

Andrew T. DeLaitschiD· 2 shared Anna MomotiD· 2 shared Anthony P. WestiD· 2 shared Arne KroidliD· 2 shared Caelan E. RadfordiD· 2 shared Christof GeldmacheriD· 2 shared Christoph KreeriD· 2 shared Colin Havenar‐DaughtoniD· 2 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Andrew T. DeLaitschORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 5, 2025

Identification of a broad and potent V3 glycan site bNAb targeting anN332gp120 glycan-independent epitope

Lutz Gieselmann, Andrew T. DeLaitsch, Malena Rohde…·Florian Klein

This paper identifies a potent, broad neutralizing antibody targeting a glycan-independent V3 epitope on HIV-1 Env, showing enhanced neutralization potency and resistance to escape mutations.

2 citations

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintAug 27, 2025

Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy

Lutz Gieselmann, Andrew T. DeLaitsch, Malena Rohde…·Florian Klein

The paper identifies a new broadly neutralizing antibody, 04_A06, with high potency and breadth against HIV-1 strains, showing potential for prevention and therapy.

1 citation

humanproteomics

𝕏 PostBluesky